Role of Ku70 and Bax in epigallocatechin-3-gallate‑induced apoptosis of A549 cells in vivo

Jing-Jing,Li; Qi-Hua,Gu; Min,Li; Hua-Ping,Yang; Li-Ming,Cao; Cheng-Ping,Hu

doi:10.3892/ol.2012.972

Role of Ku70 and Bax in epigallocatechin-3-gallate‑induced apoptosis of A549 cells in vivo

Authors:
- Li Jing-Jing
- Gu Qi-Hua
- Li Min
- Yang Hua-Ping
- Cao Li-Ming
- Hu Cheng-Ping
View Affiliations

Affiliations: Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: October 16, 2012 https://doi.org/10.3892/ol.2012.972
Pages: 101-106

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

EGCG (epigallocatechin-3-gallate), the major catechin found in green tea, has been demonstrated to inhibit proliferation and induce apoptosis in a number of types of tumors. Recent studies reveal that EGCG has various anticancer effects. This study investigated a further possible molecular mechanism of the anticancer effects of EGCG in murine lung cancer xenografts. In the study, A549 human lung cancer cells were injected into nude mice. Tumor volume was used to measure cancer cell growth. The weight of the animals was used to assess the toxicity of the drugs. The expression of protein and mRNA was assayed by western blot analysis and RT-PCR, respectively. The interaction between Bax and Ku70 was determined by immunoprecipitation. Our results suggest that EGCG induced A549 lung cancer cell apoptosis in vivo, and had less toxic effects compared to classical anticancer drugs. EGCG may inhibit the surrogate markers of proliferation and apoptosis (caspase 3) in A549 tumor xenografts in vivo. In addition, EGCG downregulated the expression of Bcl-xl and upregulated the expression of Bax mRNA and protein. Further experiments indicated that EGCG downregulated the protein expression of Ku70 and interrupted the binding of Ku70 and Bax. This is the first study demonstrating that the induction of apoptosis by EGCG may be caused by the downregulation of Ku70 and that EGCG disrupts the interaction between Ku70 and Bax in lung cancer.

View Figures

View References

1	Lu YP, Lou YR, Xie JG, et al: Topical applications of caffeine or (−)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA. 99:12455–12460. 2002.
2	Syed DN, Afaq F, Kweon MH, et al: Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene. 26:673–682. 2007. View Article : Google Scholar : PubMed/NCBI
3	Lee MH, Han DW, Hyon SH and Park JC: Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-kappaB. Apoptosis. 16:75–85. 2011. View Article : Google Scholar : PubMed/NCBI
4	Tsukamoto S, Hirotsu K, Kumazoe M, et al: Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cdelta and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochem J. 443:525–534. 2012. View Article : Google Scholar
5	Adachi S, Nagao T, Ingolfsson HI, et al: The inhibitory effect of (−)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 67:6493–6501. 2007.
6	Zhang G, Wang Y, Zhang Y, et al: Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med. 12:163–176. 2012. View Article : Google Scholar : PubMed/NCBI
7	Wei LH, Kuo ML, Chen CA, et al: Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 22:1517–1527. 2003. View Article : Google Scholar : PubMed/NCBI
8	Wang X, Hao MW, Dong K, Lin F, Ren JH and Zhang HZ: Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Arch Pharm Res. 32:1263–1269. 2009. View Article : Google Scholar : PubMed/NCBI
9	Featherstone C and Jackson SP: Ku, a DNA repair protein with multiple cellular functions. Mutat Res. 434:3–15. 1999. View Article : Google Scholar : PubMed/NCBI
10	Martinez JJ, Seveau S, Veiga E, Matsuyama S and Cossart P: Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell. 123:1013–1023. 2005. View Article : Google Scholar : PubMed/NCBI
11	Kusano K, Johnson-Schlitz DM and Engels WR: Sterility of Drosophila with mutations in the Bloom syndrome gene -complementation by Ku70. Science. 291:2600–2602. 2001. View Article : Google Scholar : PubMed/NCBI
12	Pace P, Mosedale G, Hodskinson MR, Rosado IV, Sivasubramaniam M and Patel KJ: Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway. Science. 329:219–223. 2010. View Article : Google Scholar : PubMed/NCBI
13	Du T, Caragounis A, Parker SJ, et al: A potential copper-regulatory role for cytosolic expression of the DNA repair protein XRCC5. Free Radic Biol Med. 51:2060–2072. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tonotsuka N, Hosoi Y, Miyazaki S, et al: Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. Int J Mol Med. 18:441–447. 2006.PubMed/NCBI
15	Hosoi Y, Watanabe T, Nakagawa K, et al: Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectalcancer. Int J Oncol. 25:461–468. 2004.PubMed/NCBI
16	Gullo C, Au M, Feng G and Teoh G: The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta. 1765:223–234. 2006.PubMed/NCBI
17	Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol. 5:320–329. 2003. View Article : Google Scholar : PubMed/NCBI
18	Sawada M, Hayes P and Matsuyama S: Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol. 5:352–357. 2003. View Article : Google Scholar : PubMed/NCBI
19	Baliga MS, Meleth S and Katiyar SK: Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res. 11:1918–1927. 2005. View Article : Google Scholar : PubMed/NCBI
20	Milligan SA, Burke P, Coleman DT, et al: The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res. 15:4885–4894. 2009. View Article : Google Scholar : PubMed/NCBI
21	Thakur VS, Ruhul AAR, Paul RK, et al: p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Lett. 296:225–232. 2010. View Article : Google Scholar : PubMed/NCBI
22	Onoda C, Kuribayashi K, Nirasawa S, et al: (−)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int J Oncol. 38:1403–1408. 2011.
23	Li GX, Chen YK, Hou Z, et al: Pro-oxidative activities and dose-response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis. 31:902–910. 2010.
24	Singh BN, Shankar S and Srivastava RK: Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
25	Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322–1326. 1998. View Article : Google Scholar : PubMed/NCBI
26	Lessene G, Czabotar PE and Colman PM: BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov. 7:989–1000. 2008. View Article : Google Scholar : PubMed/NCBI
27	Heath-Engel HM, Chang NC and Shore GC: The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene. 27:6419–6433. 2008. View Article : Google Scholar : PubMed/NCBI
28	Kang HG, Jenabi JM, Liu XF, Reynolds CP, Triche TJ and Sorensen PH: Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells. Mol Cancer Ther. 9:1396–1407. 2010. View Article : Google Scholar : PubMed/NCBI
29	Balasubramanian S, Adhikary G and Eckert RL: The Bmi-1 polycomb protein antagonizes the (−)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis. 31:496–503. 2010.PubMed/NCBI
30	Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol. 5:320–329. 2003. View Article : Google Scholar : PubMed/NCBI
31	Weterings E and van GDC: The mechanism of non-homologous end-joining: a synopsis of synapsis. DNA Repair (Amst). 3:1425–1435. 2004. View Article : Google Scholar : PubMed/NCBI
32	Chou CH, Wang J, Knuth MW and Reeves WH: Role of a major autoepitope in forming the DNA binding site of the p70 (Ku) antigen. J Exp Med. 175:1677–1684. 1992. View Article : Google Scholar : PubMed/NCBI
33	Wu X and Lieber MR: Protein-protein and protein-DNA interaction regions within the DNA end-binding protein Ku70-Ku86. Mol Cell Biol. 16:5186–5193. 1996.PubMed/NCBI
34	Wang J, Dong X, Myung K, Hendrickson EA and Reeves WH: Identification of two domains of the p70 Ku protein mediating dimerization with p80 and DNA binding. J Biol Chem. 273:842–848. 1998. View Article : Google Scholar : PubMed/NCBI
35	Wang J, Dong X and Reeves WH: A model for Ku heterodimer assembly and interaction with DNA. Implications for the function of Ku antigen. J Biol Chem. 273:31068–31074. 1998. View Article : Google Scholar : PubMed/NCBI
36	Soderlund LK, Queseth S, Fornander T and Askmalm MS: Low expression of Ku70/80, but high expression of DNA-PKcs, predict good response to radiotherapy in early breast cancer. Int J Oncol. 37:1547–1554. 2010.PubMed/NCBI
37	Zhang F, Zhang T, Qu Y, et al: Replication-dependent gamma-H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells. Oncol Rep. 24:1297–1305. 2010.PubMed/NCBI
38	Busser B, Sancey L, Josserand V, et al: Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation. Mol Ther. 18:536–543. 2010. View Article : Google Scholar : PubMed/NCBI
39	Sawada M, Hayes P and Matsuyama S: Cytoprotective membrane-permeable peptides designed from the Bax-binding domainof Ku70. Nat Cell Biol. 5:352–357. 2003. View Article : Google Scholar : PubMed/NCBI
40	Subramanian C, Jarzembowski JA, Opipari AW Jr, Castle VP and Kwok RP: HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia. 13:726–734. 2011.PubMed/NCBI
41	Cohen HY, Lavu S, Bitterman KJ, et al: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 13:627–638. 2004. View Article : Google Scholar : PubMed/NCBI
42	Cohen HY, Miller C, Bitterman KJ, et al: Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 305:390–392. 2004. View Article : Google Scholar : PubMed/NCBI
43	Subramanian C, Opipari AW Jr, Bian X, Castle VP and Kwok RP: Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA. 102:4842–4847. 2005. View Article : Google Scholar : PubMed/NCBI
44	Busser B, Sancey L, Josserand V, et al: Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation. Mol Ther. 18:536–543. 2010. View Article : Google Scholar : PubMed/NCBI